11. ChromoSeq: WGS-based karyotyping for hematologic malignancies

      Conventional cytogenetics are a diagnostic cornerstone for hematologic malignancies but have changed little over the past 50 years. Newer whole genome sequencing (WGS) methods can provide unbiased single-nucleotide resolution of all genomic variants. We sought to determine the clinical utility of ChromoSeq, a high-coverage WGS-based assay, compared to conventional cytogenetics in hematologic malignancies.
      To read this article in full you will need to make a payment


      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect